Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 65.02M | 63.46M | 61.91M | 62.53M | 63.12M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 65.02M | 63.46M | 61.91M | 62.53M | 63.12M |
| Cost of Revenue | 10.72M | 11.23M | 11.74M | 12.60M | 13.45M |
| Gross Profit | 54.30M | 52.23M | 50.18M | 49.93M | 49.67M |
| SG&A Expenses | 35.77M | 36.32M | 36.87M | 37.57M | 38.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.11M | -1.34M | -1.57M | -1.23M | -889.80K |
| Total Operating Expenses | 51.10M | 51.34M | 51.58M | 52.70M | 53.78M |
| Operating Income | 13.92M | 12.13M | 10.33M | 9.84M | 9.34M |
| Income Before Tax | 13.31M | 11.50M | 9.69M | 9.40M | 9.11M |
| Income Tax Expenses | 663.80K | 652.40K | 641.20K | 839.00K | 1.04M |
| Earnings from Continuing Operations | 12.64 | 10.85 | 9.05 | 8.56 | 8.07 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.64M | 10.85M | 9.05M | 8.56M | 8.07M |
| EBIT | 13.92M | 12.13M | 10.33M | 9.84M | 9.34M |
| EBITDA | 15.81M | 13.82M | 11.82M | 11.06M | 10.30M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 25.06B | 25.26B | 25.46B | 25.45B | 25.44B |
| Average Diluted Shares Outstanding | 25.06B | 25.26B | 25.46B | 25.45B | 25.44B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |